BMY Bristol-Myers Squibb Company | US1101221083
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 126.792.204.288 | 123.831.258.461,19 | 109.808.515.480,7 | 91.843.253.186,45 |
| Enterprise Value | 162.769.207.296 | 160.685.258.461,19 | 146.738.515.480,7 | 127.158.253.186,45 |
| Trailing P/E | 17,39 | 17,02 | 15,57 | 15,39 |
| Forward P/E | 10,02 | - | - | - |
| Price to Sales | 2,62 | 2,55 | 2,28 | 2,57 |
| Price to Book | 6,32 | 6,17 | 5,94 | 4,95 |
| EV/Revenue | 3,36 | 3,31 | 3,04 | 3,56 |
| EV/EBITDA | 8,58 | 8,44 | 7,36 | 8,23 |